Last Price$40.7(9.8%)
Market Cap$9,261.6M
LTM Operating Income
$62.5M
YoY Growth
N/A
3Y CAGR
N/A
5Y CAGR
N/A
Stock quality & Intrinsic value
7/10
45.4% overvalued
Hims & Hers Health, Inc. Operating Income
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|
| Operating Income | ($75.8M) | ($74.4M) | ($15.1M) | ($115.0M) | ($68.7M) | ($29.5M) |
Overvalued or undervalued?
Check the intrinsic value for HIMS
and see if it's the right time to invest.
Hims & Hers Health, Inc. (HIMS) Operating Income comparison analysis
General
LTM Operating Income
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Hims & Hers Health, Inc.HIMS
$62.5M
N/A
N/A
N/A
Median Peer Set
$1,932.0M
(1.9%)
9.5%
2.6%
Unilever PLCUL
$21.2B
4.6%
2.6%
5.2%
The Procter & Gamble CompanyPG
$19.9B
6.8%
4.3%
23.9%
Colgate-Palmolive CompanyCL
$4,442.0M
9.6%
10.1%
4.6%
Kimberly-Clark CorporationKMB
$3,318.0M
11.8%
9.0%
2.1%
Kenvue Inc.KVUE
$2,589.0M
3.2%
72.3%
N/A
The Clorox CompanyCLX
$1,275.0M
(14.7%)
19.6%
3.1%
Church & Dwight Co., Inc.CHD
$807.1M
(23.7%)
(9.2%)
(0.8%)
Coty Inc.COTY
$620.2M
(18.6%)
33.3%
N/A
e.l.f. Beauty, Inc.ELF
$130.7M
(7.1%)
72.0%
67.6%
The Estée Lauder Companies Inc.EL
$102.0M
(89.6%)
(68.3%)
(44.5%)
HIMS key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|
% growth | 26.7 0.0% | 82.6 209.4% | 148.8 80.2% | 271.9 82.8% | 526.9 93.8% | 872.0 65.5% |
| Cost of Goods Sold (COGS) | 18.9 | 38.0 | 39.3 | 67.4 | 118.2 | 157.1 |
% margin | 7.8 29.2% | 44.6 54.0% | 109.5 73.6% | 204.5 75.2% | 408.7 77.6% | 714.9 82.0% |
| Operating Expenses | 83.6 | 119.0 | 124.6 | 319.5 | 477.4 | 744.4 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 11.2 | 22.4 | 29.2 | 48.2 |
| Selling, General & Administrative Expenses (SG&A) | 83.6 | 119.0 | 124.6 | 319.5 | 370.8 | 692.7 |
% margin | (75.8) (284.0%) | (74.4) (90.1%) | (15.1) (10.2%) | (115.0) (42.3%) | (68.7) (13.0%) | (29.5) (3.4%) |
| Interest Income | 0.6 | 1.9 | 0.4 | 0.4 | 2.6 | 0.0 |
| Interest Expense | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| Pre-tax Income | (75.2) | (72.0) | (18.0) | (110.8) | (65.7) | (21.6) |
% effective tax rate | 0.0 (0.0%) | 0.1 (0.1%) | 0.1 (0.7%) | (3.1) 2.8% | (0.0) 0.0% | 2.0 (9.2%) |
% margin | (75.2) (282.0%) | (72.1) (87.3%) | (18.1) (12.2%) | (107.7) (39.6%) | (65.7) (12.5%) | (23.5) (2.7%) |
| EPS | (1.12) | (2.86) | (0.51) | (0.58) | (0.32) | (0.11) |
| Diluted EPS | (1.12) | (2.86) | (0.51) | (0.58) | (0.32) | (0.11) |
% margin | 0.0 0.0% | (74.2) (89.8%) | (14.1) (9.5%) | (111.0) (40.8%) | (61.2) (11.6%) | (19.9) (2.3%) |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Hims & Hers Health, Inc.'s Operating Income?
As of today, Hims & Hers Health, Inc.'s last 12-month Operating Income is $62.5M, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is Hims & Hers Health, Inc.'s Operating Income growth rate?
Over the last year, Hims & Hers Health, Inc.'s Operating Income growth was N/A. The average annual Operating Income growth rates for Hims & Hers Health, Inc. have been N/A over the past three years, N/A over the past five years.